Literature DB >> 16815658

Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats.

Seham Abd El Sattar El Batran1, Souad E El-Gengaihi, Osama A El Shabrawy.   

Abstract

Momordica charantia L. (MC) (Cucurbitaceae) commonly known as balsam pear, bitter gourd or karela, used in several purposes in traditional medicine is an important medicinal plant. Two sets of experiments were carried out, the first experiment indicated that the LD(50) for MC juice and alcoholic extracts were 91.9 and 362.34 mg/100g b.wt., respectively, of subcutaneously "s.c." injected mice. The toxic signs were recorded within the first 24 h post-injection. The second experiment was performed to evaluate the effect of MC juice and alcoholic extracts on blood glucose and other biochemical parameters in normal and diabetic rats. Both extracts induced a significant decrease in serum glucose levels in normal and diabetic rats. The two extracts did not show any significant effect in urea, creatinine, ALT, AST and AP in normal rat, while in diabetic rats the two extracts caused a significant decrease in serum urea, creatinine, ALT, AST, AP, cholesterol and triglyceride levels. Also, these results suggested that MC extracts possesses anti-diabetic, hepato-renal protective and hypolipidemic effect in alloxan-induced diabetic rats. Thus, MC is alternative therapy that has primarily been used for lowering blood glucose levels in patients with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815658     DOI: 10.1016/j.jep.2006.05.015

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  11 in total

Review 1.  Alternative Medicine in Diabetes - Role of Angiogenesis, Oxidative Stress, and Chronic Inflammation.

Authors:  Mohamed F El-Refaei; Suha H Abduljawad; Ahmed H Alghamdi
Journal:  Rev Diabet Stud       Date:  2015-02-10

2.  Investigation of the Blood Glucose Lowering Potential of the Jamaican Momordica charantia (Cerasee) Fruit in Sprague-Dawley Rats.

Authors:  A Burnett; M L McKoy; P Singh
Journal:  West Indian Med J       Date:  2015-04-29       Impact factor: 0.171

Review 3.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

4.  Hypoglycaemic and hypolipidaemic effects of Withania somnifera root and leaf extracts on alloxan-induced diabetic rats.

Authors:  Rajangam Udayakumar; Sampath Kasthurirengan; Thankaraj Salammal Mariashibu; Manoharan Rajesh; Vasudevan Ramesh Anbazhagan; Sei Chang Kim; Andy Ganapathi; Chang Won Choi
Journal:  Int J Mol Sci       Date:  2009-05-20       Impact factor: 6.208

5.  The effects of Momordica charantia on obesity and lipid profiles of mice fed a high-fat diet.

Authors:  Jun Wang; Ho Kyung Ryu
Journal:  Nutr Res Pract       Date:  2015-06-19       Impact factor: 1.926

Review 6.  Recent Advances in Momordica charantia: Functional Components and Biological Activities.

Authors:  Shuo Jia; Mingyue Shen; Fan Zhang; Jianhua Xie
Journal:  Int J Mol Sci       Date:  2017-11-28       Impact factor: 5.923

Review 7.  The Role of Momordica charantia in Resisting Obesity.

Authors:  Meiqi Fan; Eun-Kyung Kim; Young-Jin Choi; Yujiao Tang; Sang-Ho Moon
Journal:  Int J Environ Res Public Health       Date:  2019-09-04       Impact factor: 3.390

Review 8.  The Effect of Momordica charantia in the Treatment of Diabetes Mellitus: A Review.

Authors:  Zhuo Liu; Jing Gong; Wenya Huang; Fuer Lu; Hui Dong
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-16       Impact factor: 2.629

9.  Hypoglycemic herbs and their action mechanisms.

Authors:  Hongxiang Hui; George Tang; Vay Liang W Go
Journal:  Chin Med       Date:  2009-06-12       Impact factor: 5.455

10.  Antioxidant Potential of Momordica Charantia in Ammonium Chloride-Induced Hyperammonemic Rats.

Authors:  A Justin Thenmozhi; P Subramanian
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.